Two blood-thinner schedules for clot prevention in very obese surgery patients
Part of Hormones & metabolism clinical trials.
This study compares two different schedules of bemiparin (a blood thinner) to prevent dangerous blood clots after surgery in people with very high body weight. It may help find the safest and most effective dose/timing for clot prevention around the time of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for surgery in general surgery, gynecology, or bariatric (weight-loss) surgery
- Your clot risk is rated moderate to very high (using the Caprini risk system)
- Your BMI is 40 or higher
- You can understand the study and sign informed consent
- You must be able to follow the study plan and return for follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood-thinning medications, rivaroxaban (a pill) and enoxaparin (a shot), to prevent dangerous blood clots after weight-loss surgery. If you are scheduled for bariatric surgery, this trial could help determine which approach works better for someone like you.
This trial compares two different doses of a blood-thinning medicine to prevent blood clots after weight-loss surgery. It aims to find which dose is safer and more effective for people with higher body weight.
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
This trial compares two blood thinners, Rivaroxaban (a pill) and Enoxaparin (a shot), to see which works better at preventing dangerous blood clots in the legs after emergency abdominal surgery. It may help you if you need to stay in bed for more than a day after your operation.
This trial tests two ways to prevent blood clots (deep vein thrombosis and pulmonary embolism) after colorectal cancer surgery. The study aims to find out if a new method is as good as the standard one, which could help reduce the risk of these serious complications.
This study looks at how the blood thinner enoxaparin (Lovenox) is absorbed in people with severe obesity when injected into two different body areas. It aims to see if the standard preventive dose works well, potentially improving clot prevention for people your size.
Hear when a new Morbid Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.